Company / CapEx per Share
Veracyte, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.12
FY2025
5-year range
$0.09 / $0.15
FY2021-FY2025
Trend
-19.2%
vs FY2024
Sector context
#119 of 142
Health Care
What the data says
Veracyte, Inc.'s capex per share of $0.12 is lower than 84% of companies in the Health Care sector (FY2025). CapEx per Share has fluctuated over the past 10 years, ranging from $0.05 in FY2017 to $0.15 in FY2024.
Based on SEC 10-K filings.
0.12 in FY2025 with a 5-year CAGR of +16.8%.
Declined from $0.14 to $0.12 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 142This company $0.12 Sector average $1.70
▼
-92.7% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 19.2% year-over-year.
- Ranks #119 out of 142 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | -19.2% |
| FY2024 | $0.15 | +11.3% |
| FY2023 | $0.14 | +15.2% |
| FY2022 | $0.12 | +30.1% |
| FY2021 | $0.09 | +61.6% |
| FY2020 | $0.06 | -15.2% |
| FY2019 | $0.07 | +21.5% |
| FY2018 | $0.06 | +6.8% |
| FY2017 | $0.05 | -65.8% |
| FY2016 | $0.15 | -44.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026